Second, the cohort was predominantly female and of Russian ethnicity, reflecting the high prevalence of BRCA1/2-related breast and ovarian cancers, but limiting generalizability to other racial and ethnic groups. This evidence concerns the gene BRCA1 and ovarian cancer.